(primary solid tumor cohort)
There are 119 genes with significant mutation (Q value <= 0.1) and 328 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 2000 for subtype 1, 2000 for subtype 2, 2000 for subtype 3, 2000 for subtype 4. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :
1 pathways significantly enriched with genes with copy number alteration or mutation.
2 pathways significantly enriched with marker genes of gene expression subtype 1
0 pathways significantly enriched with marker genes of gene expression subtype 2
1 pathways significantly enriched with marker genes of gene expression subtype 3
1 pathways significantly enriched with marker genes of gene expression subtype 4